Bibliografia UJ CM

1/18
Srdan Verstovsek, Ruben A. Mesa, Vikas Gupta, David Lavie, Viviane Dubruille, Nathalie Cambier, Uwe Platzbecker, Marek Hus, Blanca Xicoy, Stephen T. Oh, Jean-Jacques Kiladjian, Alessandro M. Vannucchi, Aaron T. Gerds, Miklos Egyed, Jiri Mayer, Tomasz Sacha, Jun Kawashima, Marc Morris, Mei Huang, Claire N. Harrison.
Momelotinib long-term safety and survival in myelofibrosis : integrated analysis of phase 3 randomized-controlled trials
Blood Advances
2023, abstr.
Autor korespondencyjny: Srdan Verstovsek
Online First 2023-04-12
p-ISSN: 2473-9529
e-ISSN: 2473-9537
XXX
ORG
AIF
IF: 7.500
Adres url:
Streszczenie w PubMed:
2/18
Max Topp, Monika Dlugosz-Danecka, Aleksander B[artłomiej] Skotnicki, Galina Salogub, Andreas Viardot, Andreas K. Klein, Georg Hess, Christian S. Michel, Sebastian Grosicki, Alex Gural, Sylvia E. Schwarz, Kerstin Pietzko, Ulrike Gartner, Andras Strassz, Leila Alland, Jiri Mayer.
Safety of AFM11 in the treatment of patients with B-cell malignancies : findings from two phase 1 studies
Trials
2023 : Vol. 24, nr 1, il., bibliogr., abstr.
Autor korespondencyjny: Ulrike Gartner
Open Access Creative Commons Attribution License CC-BY 4.0
e-ISSN: 1745-6215
AZ
ORG
AIF
IF: 2.500
Adres url:
3/18
Peter Hillmen, Barbara Eichhorst, Jennifer R. Brown, Nicole Lamanna, Susan M. O'Brien, Constantine S. Tam, Lugui Qiu, Maciej Kazmierczak, Keshu Zhou, Martin Simkovic, Jiri Mayer, Amanda Gillespie-Twardy, Mazyar Shadman, Alessandra Ferrajoli, Peter S. Ganly, Robert Weinkove, Sebastian Grosicki, Andrzej Mital, Tadeusz Robak, Anders Osterborg, Habte A. Yimer, Tommi Salmi, Meng Ji, Jessica Yecies, Adam Idoine, Kenneth Wu, Jane Huang, Wojciech Jurczak.
Zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma : interim analysis of a randomized phase III trial.
Journal of Clinical Oncology
2023 : Vol. 41, nr 5, s. 1035-1045, il., bibliogr. 22 poz.
Autor korespondencyjny: Peter Hillmen
Online First 2022-11-17
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 45.300
Adres url:
Streszczenie w PubMed:
4/18
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiri Mayer, Vera Yablokova, Kurt Krejcy, Hans C. Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian.
Ropeginterferon Alfa-2b : Efficacy and Safety in Different Age Groups.
HemaSphere
2020 : Vol. 4, nr 6, il., bibliogr. 15 poz.
Autor korespondencyjny: Heinz Gisslinger.
Open Access Creative Commons Attribution License CC-BY-ND 4.0.
p-ISSN: 2572-9241
LR
APZ
Adres url:
Streszczenie w PubMed:
5/18
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Dorota Krochmalczyk, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Lylia Sivcheva, Jiri Mayer, Vera Yablokova, Kurt Krejcy, Barbara Grohmann-Izay, Hans C. Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian.
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV) : a randomised, non-inferiority, phase 3 trial and its extension study.
Lancet. Haematology
2020 : Vol. 7, nr 3, s. e196-e208, sum.
Autor korespondencyjny: Heinz Gisslinger.
e-ISSN: 2352-3026
AZ
ORG
AIF
IF: 18.959
Adres url:
Streszczenie w PubMed:
DOI:
6/18
Zdenek Racil, Eva Koritakova, Tomasz Sacha, Hana Klamova, Petra Belohlavkova, Edgar Faber, Ludmila Malaskova, Jirina Prochazkova, Daniela Zackova, Jaroslava Voglova, Joanna Wącław, Petr Cetkovsky, Pavel Zak, Jiri Mayer.
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.
American Journal of Hematology
2018 : Vol. 93, nr 10, s. E342-E345, bibliogr. 6 poz.
Autor korespondencyjny: Zdenek Racil.
p-ISSN: 0361-8609
LR
AIF
IF: 6.137
Adres url:
Streszczenie w PubMed:
7/18
Wojciech Jurczak, Krzysztof Chojnowski, Jiri Mayer, Katarzyna Krawczyk, Brian D. Jamieson, Wei Tian, Lee F. Allen.
Phase 3 randomised study of avatrombopag, a novel thrombopoietin receptor agonist for the treatment of chronic immune thrombocytopenia.
British Journal of Haematology
2018 : Vol. 183, nr 3, s. 479-490, il., bibliogr., sum.
Autor korespondencyjny: Wojciech Jurczak.
Open Access Creative Commons Attribution License CC-BY-NC 4.0.
p-ISSN: 0007-1048
AZ
ORG
AIF
IF: 5.206
Adres url:
Streszczenie w PubMed:
8/18
Luca Arcaini, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon Rule, Jose Cabecadas, Elias Campo, Stefano A. Pileri, Tsvetan Biyukov, Meera Patturajan, Marie-Laure Casadebaig Bravo, Marek Trneny.
Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma
British Journal of Haematology
2018 : Vol. 180, nr 2, s. 224-235, il., bibliogr., sum.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
Autor korespondencyjny: Luca Arcaini.
p-ISSN: 0007-1048
AZ
ORG
AIF
IF: 5.206
Adres url:
Streszczenie w PubMed:
9/18
Heinz Gisslinger, Christoph Klade, Pencho Georgiev, Aleksander Skotnicki, Liana Gercheva-Kyuchukova, Miklos Egyed, Viktor Rossiev, Petr Dulicek, Arpad Illes, Halyna Pylypenko, Liliya Sivcheva, Jiri Mayer, Barbara Grohmann-Izay, Hans Hasselbalch, Robert Kralovics, Jean-Jacques Kiladjian.
Final Results from PROUD-PV a Randomized Controlled Phase 3 Trial Comparing Ropeginterferon Alfa-2b to Hydroxyurea in Polycythemia Vera Patients.
Blood
2016 : Vol. 128, nr 22, s. 475
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971
SZZ
SIF
Adres url:
10/18
Asher Chanan-Khan, Paula Cramer, Fatih Demirkan, Graeme Fraser, Rodrigo Santucci Silva, Sebastian Grosicki, Aleksander Pristupa, Ann Janssens, Jiri Mayer, Nancy L. Bartlett, Marie-Sarah Dilhuydy, Halyna Pylypenko, Javier Loscertales, Abraham Avigdor, Simon Rule, Diego Villa, Olga Samoilova, Panagiots Panagiotidis, Andre Goy, Anthony Mato, Miguel A. Pavlovsky, Claes Karlsson, Michelle Mahler, Mariya Salman, Steven Sun, Charles Phelps, Sriram Balasubramanian, Angela Howes, Michael Hallek, HELIOS investigators.
Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.
Lancet. Oncology
2016 : Vol. 17, nr 2, s. 200-211, il., bibliogr. 22 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
11/18
Marek Trneny, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, John Radford, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon Rule, Boris Afanasyev, Kamil Kaplanov, Antoine Thyss, Alexej Kuzmin, Sergey Voloshin, Kazimierz Kuliczkowski, Agnieszka Giza, Noel Milpied, Caterina Stelitano, Reinhard Marks, Lorenz Trumper, Tsvetan Biyukov, Meera Patturajan, Marie-Laure Casadebaig Bravo, Casadebaig Bravo, Luca Arcaini.
Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial.
Lancet. Oncology
2016 : Vol. 17, nr 3, s. 319-331, il., bibliogr. 28 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 33.900
Adres url:
Streszczenie w PubMed:
12/18
Marek Trneny, Thierry Lamy, Jan Walewski, David Belada, Jiri Mayer, John A. Radford, Wojciech Jurczak, Franck Morschhauser, Julia Alexeeva, Simon A. Rule, Boris V. Afanasyev, Kamil Kaplanov, Antoine Thyss, Alexej Kuzmin, Sergey Voloshin, Kazimierz Kuliczkowski, Agnieszka Giza, Noel Milpied, Caterina Stelitano, Reinhard Marks, Lorenz Trumper, Tsvetan Biyukov, Evelyn Barnett, Marie-Laure Casadebaig Bravo, Luca Arcaini.
Outcomes Following Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma Patients at Risk of Bleeding Events Because of Multiple Comorbidities or Treatment: A Post-Hoc Subgroup Analysis of the SPRINT (MCL-002) Trial.
Blood
2016 : Vol. 128, nr 22, s. 2978
58th ASH Annual Meeting & Exposition, San Diego, California, 3-5 December 2016.
p-ISSN: 0006-4971
SZZ
SIF
Adres url:
13/18
Bertrand Coiffier, Evgenii A. Osmanov, Xiaonan Hong, Adriana Scheliga, Jiri Mayer, Fritz Offner, Simon Rule, Adriana Teixeira, Jan Walewski, Sven Vos, de, Michael Crump, Ofer Shpilberg, Dixie-Lee Esseltine, Eugene Zhu, Christopher Enny, Panteli Theocharous, Helgi Velde, van de, Yusri A. Elsayed, Pier Luigi Zinzani, LYM-3001 study investigators.
Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma : a randomised phase 3 trial.
Lancet. Oncology
2011 : Vol. 12, nr 8, s. 773-784, il., bibliogr. 44 poz., sum.
p-ISSN: 1470-2045
AZ
ORG
AIF
IF: 22.589
14/18
Martin C. Muller, Umang Munjal, Philipp Erben, Thomas Lion, Gerlinde Mitterbauer-Hohendann, Hakim El Housni, Nancy Boeckx, Renata Zadro, Jiri Mayer, Peter Rohon, Jana Rulcova, Lykke Grubach, Kadri Raudsepp, Veli Kairisto, Francois-Xavier Mahon, Claude Preudhomme, Sandrine Hayette, Jean Gabert, Jean-Michel Cayuela, Christian Thiede, Lars Galonska, Heike Pfeifer, Carsten Hirt, Philippe Schafhausen, Nils von Neuhoff, Martin Roskos, Christiane Pott, Thoralf Lange, Georg Hess, Susanne Schnittger, Annika Dufour, Steffen Koschmieder, Frank Stegelmann, Katerina Zoi, Kostas Stamatopoulos, Hajnalka Andrikovics, Tali Tohami, Giovanni Martinelli, Barbara Izzo, Enrico Gottardi, Mindaugas Stoskus, Dag Andre Nymoen, Tomasz Sacha, Joana Diamond, Rodica Talmaci, Andrey Misyurin, Michael V. Dubina, Tadej Pajic, Josep F. Nomdedeu, Dolors Colomer, Gisela Barbany-Bustinza, Hans Ehrencrona, Elisabeth Oppliger Leibundgut, Jeroen Janssen, Vincent H.J. Van der elden, Peter J.M. Valk, Ugur Ozbek, Lihui Wang, Gareth Gerrard, Helen E. White, Thomas Schenk, Thomas Ernst, Rudiger Hehlmann, Giuseppe Saglio, Andreas Hochhaus, Nicholas C.P. Cross.
Stability of conversion factors for BCR-ABL monitoring - implications for the frequency of validation rounds.
Blood
2010 : Vol. 116, nr 21, abstr. 893
52nd ASH Annual Meeting, Orlando, FL, December 4-7, 2010.
SZZ
SIF
15/18
Sebastian Giebel, Beata Stella-Holowiecka, Malgorzata Krawczyk-Kulis, Nicola Goekbuget, Dieter Hoelzer, Michael Doubek, Jiri Mayer, Beata Piatkowska-Jakubas, Aleksander Skotnicki, Herve Dombret, Joseph-Maria Ribera, Pier Paolo Piccaluga, Tomasz Czerw, Maria Sadus-Wojciechowska, Slawomira Kyrcz-Krzemien, Jerzy Holowiecki.
Status of minimal residual disease determines outcome of autologous HSCT in adults with high-risk acute lymphoblastic leukemia.
Blood
2009 : Vol. 114, nr 22, abstr. 2321
51st ASH Annual Meeting, New Orleans, USA, [5-8 December 2009].
SZZ
SIF
16/18
Peter Hillmen, Aleksander Skotnicki, Tadeusz Robak, Branimir Jaksic, Cynthia Sirard, Jiri Mayer.
Alemtuzumab (CAMPATH, MABCAMPATH) has superior progression free survival (PFS) vs Chlorambucil as front -line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL).
Blood
2006 : Vol. 108, nr 11 Part 1, s. 93a, abstr. 301
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
17/18
Tadeusz Robak, Anna Dmoszynska, Raouf Fetni, Ying Wang, Malika Belkacz, Cynthia Sirard, Mark Goldberg, Aleksander Skotnicki, Jiri Mayer, Peter Hillmen.
Incidence of genomic aberrations and associated efficacy from a phase III study comparing alemtuzumab (CAMPATH, MABCAMPATH) vs chlorambucil as first line therapy for B-cell chronic lymphocytic leukemia (BCLL).
Blood
2006 : Vol. 108, nr 11 Part 1, s. 593a, abstr. 2093
American Society of Hematology Forty-eight annual meeting, Orlando, Florida, December 9-12, 2006.
SZZ
SIF
18/18
Peter Hillmen, Aleksander B. Skotnicki, Tadeusz Robak, Jiri Mayer, Branimir Jaksic, Vojo Vukovic, Steven Weitman.
Preliminary safety and efficacy report of a randomized trial of alemtuzumab vs chlorambucil as front-line therapy in 297 patients with progressive B-Cell chronic lymphocytic leukemia.
Blood
2004 : Vol. 104, nr 11 Part 1, s. 687a, abstr. 2505
American Society of Hematology Forty-six annual meeting, San Diego, California, December 4-7, 2004.
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ